Mohamed MF, Coppola S, Feng T, Camp HS, Kim E, Othman AA. Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects. Clin Pharmacol Drug Dev 2021. [PMID: 34109764 DOI: 10.1002/cpdd.957][Reference Citation Analysis]
2
Muensterman E, Engelhardt B, Gopalakrishnan S, Anderson JK, Mohamed MF. Upadacitinib pharmacokinetics and exposure-response analyses of efficacy and safety in psoriatic arthritis patients - Analyses of phase III clinical trials. Clin Transl Sci 2021. [PMID: 34464029 DOI: 10.1111/cts.13146][Reference Citation Analysis]
3
Mohamed MF, Gopalakrishnan S, Teixeira HD, Othman AA. Exposure-Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis-Analyses of Phase 2b Study to Support Selection of Phase 3 Doses. J Clin Pharmacol 2021;61:628-35. [PMID: 33156550 DOI: 10.1002/jcph.1782][Cited by in F6Publishing: 1][Reference Citation Analysis]